AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 74 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,529,133 | -38.4% | 582,900 | -23.3% | 0.01% | -36.8% |
| Q2 2023 | $7,357,768 | +132.9% | 760,100 | +163.6% | 0.02% | +137.5% |
| Q1 2023 | $3,159,768 | +823.5% | 288,300 | +264.0% | 0.01% | +700.0% |
| Q4 2022 | $342,144 | -29.2% | 79,200 | +23.4% | 0.00% | 0.0% |
| Q3 2022 | $483,000 | -42.3% | 64,200 | +13.0% | 0.00% | -50.0% |
| Q3 2020 | $837,000 | -40.9% | 56,800 | -34.9% | 0.00% | -50.0% |
| Q2 2020 | $1,417,000 | +32.3% | 87,200 | +18.2% | 0.00% | 0.0% |
| Q1 2020 | $1,071,000 | +1408.5% | 73,800 | +577.1% | 0.00% | – |
| Q1 2019 | $71,000 | -51.4% | 10,900 | -57.9% | 0.00% | – |
| Q2 2018 | $146,000 | -25.9% | 25,900 | -31.7% | 0.00% | -100.0% |
| Q1 2018 | $197,000 | -10.0% | 37,900 | -21.7% | 0.00% | 0.0% |
| Q4 2017 | $219,000 | -37.1% | 48,400 | -12.8% | 0.00% | 0.0% |
| Q3 2017 | $348,000 | +21.7% | 55,500 | +19.1% | 0.00% | 0.0% |
| Q2 2017 | $286,000 | – | 46,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 400,434 | $2,723,000 | 2.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 231,681 | $1,580,000 | 1.46% |
| NEA Management Company, LLC | 4,808,483 | $32,794,000 | 1.30% |
| Kazazian Asset Management, LLC | 117,056 | $798,000 | 1.08% |
| Vivo Capital, LLC | 1,213,290 | $8,275,000 | 1.06% |
| Polar Capital LLP | 3,312,723 | $22,593,000 | 0.24% |
| Patriot Financial Group Insurance Agency, LLC | 16,850 | $115,000 | 0.08% |
| MGO ONE SEVEN LLC | 11,000 | $75,000 | 0.03% |
| Hudson Bay Capital Management LP | 275,000 | $1,876,000 | 0.02% |
| Candriam S.C.A. | 157,500 | $1,074,000 | 0.02% |